Company Filing History:
1 out of 50 
1 out of 3,540 
1 out of 122 
Years Active: 2009-2014
Title: The Innovative Contributions of Inventor Michael Buchmeier
Introduction
Michael Buchmeier, an accomplished inventor based in Encinitas, California, has made notable contributions to the field of antiviral research. With two patents to his name, Buchmeier focuses on developing innovative compounds and methods aimed at combating various viral infections.
Latest Patents
Among his recent inventions, Buchmeier has patented a method and oligonucleotide compound designed to treat nidovirus infections. This patent describes a compound that has a nuclease-resistant backbone, can be effectively absorbed by infected animal cells, consists of 8-25 nucleotide bases, and disrupts base pairing between the transcriptional regulatory sequences of the viral genome. The method involves administering this compound in an effective amount to inhibit viral replication.
In addition, he has also developed an antisense antiviral compound and method targeting Arenavirus infections. This invention comprises substantially uncharged morpholino oligonucleotides, which have a sequence of 12-40 subunits, including a targeting sequence that complements specific regions of viral RNA. These compounds are specifically beneficial in treating Arenavirus infections in mammals.
Career Highlights
Michael Buchmeier has collaborated with prominent organizations in his career. His work with Avi Biopharma, Inc. showcases his dedication to advancing viral treatment methodologies. Furthermore, his association with the United States Department of Health and Human Services demonstrates his commitment to public health initiatives.
Collaborations
Throughout his career, Buchmeier has worked closely with esteemed colleagues such as Benjamin Neuman and David A Stein. Their collaboration has propelled advancements in antiviral therapies, strengthening Buchmeier's contributions in this crucial area of study.
Conclusion
Michael Buchmeier stands out as an innovative inventor whose work has the potential to significantly impact the field of virology. With a focus on developing effective antiviral compounds, his two patents underline his commitment to fighting viral infections. As research in this area continues to evolve, Buchmeier’s inventions pave the way for future breakthroughs in treatment methodologies.